{"id":497551,"date":"2024-01-26T19:30:15","date_gmt":"2024-01-27T00:30:15","guid":{"rendered":"https:\/\/platohealth.ai\/public-equity-roundup-cg-arrivent-ipos-stoke-optimism-for-growing-queue\/"},"modified":"2024-01-27T07:17:04","modified_gmt":"2024-01-27T12:17:04","slug":"public-equity-roundup-cg-arrivent-ipos-stoke-optimism-for-growing-queue","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/public-equity-roundup-cg-arrivent-ipos-stoke-optimism-for-growing-queue\/","title":{"rendered":"Public equity roundup: CG, ArriVent IPOs stoke optimism for growing queue","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
ARTICLE | Finance<\/p>\n
\n By Paul Bonanos, Director of Biopharma Intelligence<\/span>\n<\/p>\n January 27, 2024 12:30 AM UTC<\/p>\n<\/div>\n<\/div>\n<\/div>\n New listings from CG Oncology and ArriVent provided hopeful signs for a 2024 rebound in the biotech IPO market, while cash continued to flow into biopharmas via follow-ons and PIPEs.<\/p>\n Enthusiasm for the listing by CG Oncology Inc.<\/a><\/b> (NASDAQ:CGON) gained momentum during the week, as the company first upsized its proposal, then priced above expectations and gained value in the aftermarket. An initial 11.8 million-share proposal swelled to 17 million shares; CG then sold 20 million shares at the top of its range, raising $380 million \u2014 the most for a new-to-NASDAQ biotech since the $621 million offering by Acelyrin Inc. in May 2023…<\/p>\n ARTICLE | Finance Plus: Follow-ons for Sagimet, Tourmaline and Adicet, and PIPEs for Kura, ORIC and CalciMedica By Paul Bonanos, Director of Biopharma Intelligence January 27, 2024 12:30 AM UTC New listings from CG Oncology and ArriVent provided hopeful signs for a 2024 rebound in the biotech IPO market, while cash continued to flow into […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":2,"featured_media":497555,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[50],"tags":[],"acf":[],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/497551"}],"collection":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/comments?post=497551"}],"version-history":[{"count":1,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/497551\/revisions"}],"predecessor-version":[{"id":497554,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/497551\/revisions\/497554"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media\/497555"}],"wp:attachment":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media?parent=497551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/categories?post=497551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/tags?post=497551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/span><\/div>\n
\n